Research Paper Volume 15, Issue 23 pp 13738—13752
Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle
Figure 6. RFC3 expression had an unfavorable effect on patients with ER-positive breast cancer. (A) RFC3 expression had no effect on the OS of ER-positive patients. (B) Patients with high expression of RFC3 in ER-positive breast cancer had worse DFS. (C) Patients with high expression of RFC3 in ER-positive breast cancer had worse DMFS. (D) Patients with high expression of RFC3 in ER-positive breast cancer had worse RFS.